ATP stimulates chemokine production via a store-operated calcium entry pathway in C6 glioma cells

BMC Cancer. 2009 Dec 15:9:442. doi: 10.1186/1471-2407-9-442.

Abstract

Background: Glioma present as one of the most challenging cancers to treat, however, understanding of tumor cell biology is not well understood. Extracellular adenosine triphosphate (ATP) could serve as a critical signaling molecule regulating tumor development. This study has examined pharmacological modulation of calcium (Ca2+) entry through store-operated channels (SOC) on cellular expression and production of immune-cell mobilizing chemokines in ATP-stimulated C6 glioma cells.

Methods: Calcium spectrofluorometry was carried out to measure mobilization of intracellular Ca2+ [Ca2+]i following ATP stimulation of rat C6 glioma cells. Pretreatment with two inhibitors of SOC, SKF96365 or gadolinium, was used to examine for effects on [Ca2+]i. RT-PCR was performed to determine effects of purinergic stimulation on C6 cell expression of metabotropic P2Y receptors (P2YR) and the chemokines, monocyte chemoattractant protein-1 (MCP-1) and interleukin-8 (IL-8). ELISA was carried out to measure production of MCP-1 and IL-8 with ATP stimulation of glioma cells.

Results: Application of ATP (at 100 microM) to C6 glioma induced an increase in [Ca2+]i with the response exhibiting two components of decay. In the presence of the SOC inhibitors, SKF96365 or gadolinium, or with Ca2+-free solution, ATP responses lacked a slow phase suggesting the secondary component was due to SOC-mediated influx of Ca2+. RT-PCR confirmed expression of purinergic P2Y-subtype receptors in C6 cells which would serve as a precursor to activation of SOC. In addition, ATP-stimulated C6 cells showed enhanced expression of the chemokines, MCP-1 and IL-8, with SKF96365 or gadolinium effective in reducing chemokine expression. Gadolinium treatment of ATP-stimulated C6 cells was also found to inhibit the production of MCP-1 and IL-8.

Conclusion: These results suggest ATP-induced Ca2+ entry, mediated by activation of SOC in C6 glioma, as a mechanism leading to increased cellular expression and release of chemokines. Elevated levels of MCP-1 and IL-8 are predicted to enhance the mobility of tumor cells and promote recruitment of microglia into developing tumors thereby supporting tumor growth.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenosine Triphosphate / pharmacology*
  • Animals
  • Calcium / metabolism*
  • Cell Line, Tumor
  • Cell Movement / genetics
  • Chemokine CCL2 / genetics
  • Chemokine CCL2 / metabolism
  • Chemokines / genetics
  • Chemokines / metabolism*
  • Gene Expression Regulation, Neoplastic / drug effects
  • Glioma / diagnosis
  • Glioma / genetics
  • Glioma / metabolism
  • Glioma / pathology*
  • Interleukin-8 / genetics
  • Interleukin-8 / metabolism
  • Microglia / pathology
  • Neoplasm Invasiveness
  • Prognosis
  • Rats
  • Receptors, Purinergic P2 / genetics
  • Receptors, Purinergic P2 / metabolism
  • Signal Transduction / drug effects
  • Signal Transduction / genetics

Substances

  • Ccl2 protein, rat
  • Chemokine CCL2
  • Chemokines
  • Interleukin-8
  • Receptors, Purinergic P2
  • Adenosine Triphosphate
  • Calcium